Caveolin‐1 upregulates Fut8 expression by activating the Wnt/β‐catenin pathway to enhance HCC cell proliferative and invasive ability
Cheng Zhang,Qiong Wu,Huang Huang,Xixi Chen,Tianmiao Huang,Wenli Li,Jianing Zhang,Yubo Liu
DOI: https://doi.org/10.1002/cbin.11426
IF: 4.473
2020-08-08
Cell Biology International
Abstract:<p>Caveolin‐1 (Cav‐1), a critical structural protein of caveolae, plays an oncogenic role by participating in abnormal protein glycosylation in hepatocellular carcinoma (HCC). However, the mechanism by which Cav‐1 regulates glycosylation and glycosyltransferase expression has yet to be fully defined. Here, we show that Cav‐1 promotes the expression of α1,6‐fucosyltransferase (Fut8), which catalyzes the transfer of GDP‐fucose to the core structure of the N‐sugar chain. In this study, we show that the mouse HCC cell line, Hepa1‐6, which has low Fut8 transcriptional and protein levels, also, lacks Cav‐1 expression, whereas the mouse HCC cell line, Hca‐F, has strong Fut8 expression and high transcriptional and protein levels of Cav‐1. Subsequently, Cav‐1 overexpression in Hepa1‐6 was found to activate Wnt/β‐catenin signaling, which leads to downstream binding of the T cell factor (TCF)/lymphoid enhancer factor (LEF) to the <i>Fut8 </i> promoter region to activation of its transcription. On the contrary, knockdown of Cav‐1 expression in Hca‐F caused the Wnt/β‐catenin pathway to be significantly inhibited, which attenuates the expression of Fut8. We further show that Cav‐1‐induced up‐regulation of Fut8 expression enhanced proliferation and invasion by mouse HCC cells <i>in vitro </i>. Our current findings provide molecular evidence that Cav‐1 plays an important role in regulating glycosyltransferase expression and may participate in abnormal glycosylation which mediates the proliferation and invasion of HCC.</p><p>This article is protected by copyright. All rights reserved.</p>
cell biology